Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Ciechanover Isaac E.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Ciechanover Isaac E. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ATRA / Atara Biotherapeutics, Inc. | Chief Executive Officer, Director | 290 687 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Ciechanover Isaac E.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ATRA / Atara Biotherapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ATRA / Atara Biotherapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ATRA / Atara Biotherapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Ciechanover Isaac E. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-05-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 290 687 | −0,51 | 23,70 | −35 550 | 6 889 282 |
2019-05-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 425 | 292 187 | −0,49 | 22,72 | −32 376 | 6 638 489 |
2019-05-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −725 | 293 612 | −0,25 | 23,30 | −16 892 | 6 841 160 |
2019-05-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 294 337 | −0,74 | 22,85 | −50 270 | 6 725 600 |
2019-05-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 296 537 | −1,30 | 24,92 | −97 188 | 7 389 702 |
2019-05-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 300 437 | −0,13 | 24,95 | −9 980 | 7 495 903 |
2019-05-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 500 | 300 837 | −1,15 | 24,23 | −84 805 | 7 289 281 |
2019-04-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 304 337 | −1,27 | 33,47 | −130 533 | 10 186 159 |
2019-04-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 308 237 | −0,10 | 33,99 | −10 197 | 10 476 976 |
2019-04-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 308 537 | −1,15 | 33,57 | −120 852 | 10 357 587 |
2019-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 312 137 | −1,23 | 36,27 | −141 453 | 11 321 209 |
2019-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 316 037 | −1,22 | 37,04 | −144 456 | 11 706 010 |
2019-04-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 319 937 | −0,06 | 41,70 | −8 340 | 13 341 373 |
2019-04-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 700 | 320 137 | −1,14 | 39,81 | −147 297 | 12 744 654 |
2019-04-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 323 837 | −0,09 | 38,59 | −11 577 | 12 496 870 |
2019-04-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 324 137 | −0,49 | 38,02 | −60 832 | 12 323 689 |
2019-04-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 000 | 325 737 | −0,61 | 36,75 | −73 500 | 11 970 835 |
2019-03-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 327 737 | −1,18 | 38,73 | −151 047 | 12 693 254 |
2019-03-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 200 | 331 637 | −0,96 | 40,48 | −129 536 | 13 424 666 |
2019-03-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 334 837 | −0,21 | 39,10 | −27 370 | 13 092 127 |
2019-03-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 335 537 | −1,15 | 36,13 | −140 907 | 12 122 952 |
2019-03-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 700 | 339 437 | −1,08 | 36,20 | −133 940 | 12 287 619 |
2019-03-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 343 137 | −0,06 | 35,22 | −7 044 | 12 085 285 |
2019-02-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
F - Taxes | −1 176 | 332 243 | −0,35 | 40,45 | −47 569 | 13 439 229 | |
2019-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 342 138 | −1,13 | 39,01 | −152 139 | 13 346 803 |
2019-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 346 038 | −1,11 | 38,52 | −150 228 | 13 329 384 |
2019-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
F - Taxes | −20 324 | 334 618 | −5,73 | 38,49 | −782 271 | 12 879 447 | |
2019-02-12 |
|
4/A | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
F - Taxes | −24 683 | 375 611 | −6,17 | 38,47 | −949 555 | 14 449 755 | |
2019-02-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
F - Taxes | −24 683 | 375 611 | −6,17 | ||||
2019-01-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −430 | 296 452 | −0,14 | 35,82 | −15 403 | 10 618 911 |
2019-01-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 470 | 296 882 | −1,16 | 34,98 | −121 381 | 10 384 932 |
2019-01-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 300 352 | −0,03 | 36,58 | −3 658 | 10 986 876 |
2019-01-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −800 | 300 452 | −0,27 | 35,59 | −28 472 | 10 693 087 |
2019-01-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 000 | 301 252 | −0,99 | 34,84 | −104 520 | 10 495 620 |
2019-01-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 4 078 | −35,04 | 34,50 | −75 900 | 140 691 |
2019-01-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 700 | 6 278 | −21,31 | 33,93 | −57 681 | 213 013 |
2019-01-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 000 | 7 978 | −20,04 | 35,16 | −70 320 | 280 506 |
2019-01-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 900 | 9 978 | −16,00 | 34,51 | −65 569 | 344 341 |
2018-12-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 11 878 | −4,04 | 35,40 | −17 700 | 420 481 |
2018-12-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 400 | 12 378 | −21,55 | 34,60 | −117 640 | 428 279 |
2018-12-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −653 | 15 778 | −3,97 | 34,19 | −22 326 | 539 450 |
2018-12-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 247 | 16 431 | −16,50 | 32,82 | −106 567 | 539 265 |
2018-12-13 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 19 678 | −16,54 | 42,75 | −166 725 | 841 234 |
2018-12-13 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 23 578 | −14,19 | 42,56 | −165 984 | 1 003 480 |
2018-11-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 500 | 27 478 | −8,34 | 42,26 | −105 650 | 1 161 220 |
2018-11-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 29 978 | −4,46 | 41,13 | −57 582 | 1 232 995 |
2018-11-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 31 378 | −3,68 | 39,54 | −47 448 | 1 240 686 |
2018-11-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 700 | 32 578 | −7,65 | 38,65 | −104 355 | 1 259 140 |
2018-11-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 800 | 35 278 | −7,35 | 35,49 | −99 372 | 1 252 016 |
2018-11-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 38 078 | −2,81 | 34,67 | −38 137 | 1 320 164 |
2018-11-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 39 178 | −1,51 | 34,51 | −20 706 | 1 352 033 |
2018-11-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 300 | 39 778 | −7,66 | 33,89 | −111 837 | 1 348 076 |
2018-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −800 | 43 078 | −1,82 | 35,18 | −28 144 | 1 515 484 |
2018-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 700 | 43 878 | −3,73 | 34,39 | −58 463 | 1 508 964 |
2018-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 45 578 | −2,98 | 33,17 | −46 438 | 1 511 822 |
2018-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −795 | 46 978 | −1,66 | 34,26 | −27 237 | 1 609 466 |
2018-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 105 | 47 773 | −6,10 | 33,66 | −104 514 | 1 608 039 |
2018-10-05 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 50 878 | −0,20 | 41,00 | −4 100 | 2 085 998 |
2018-10-05 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 900 | 50 978 | −3,59 | 40,25 | −76 475 | 2 051 864 |
2018-10-05 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 900 | 52 878 | −3,47 | 39,58 | −75 202 | 2 092 911 |
2018-10-05 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 54 778 | −2,32 | 41,34 | −53 742 | 2 264 523 |
2018-10-05 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 600 | 56 078 | −4,43 | 40,09 | −104 234 | 2 248 167 |
2018-09-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
F - Taxes | −79 328 | 733 285 | −9,76 | 39,85 | −3 161 221 | 29 221 407 | |
2018-09-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 58 678 | −6,23 | 39,99 | −155 961 | 2 346 533 |
2018-09-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 62 578 | −5,87 | 39,62 | −154 518 | 2 479 340 |
2018-09-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 827 | 66 478 | −2,67 | 40,23 | −73 500 | 2 674 410 |
2018-09-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 073 | 68 305 | −2,95 | 39,74 | −82 381 | 2 714 441 |
2018-09-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 120 | 70 378 | −1,57 | 39,42 | −44 150 | 2 774 301 |
2018-09-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 780 | 71 498 | −3,74 | 38,45 | −106 891 | 2 749 098 |
2018-08-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 74 278 | −4,99 | 36,69 | −143 091 | 2 725 260 |
2018-08-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 78 178 | −4,75 | 36,04 | −140 556 | 2 817 535 |
2018-08-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 82 078 | −0,36 | 37,75 | −11 325 | 3 098 444 |
2018-08-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 82 378 | −4,19 | 37,35 | −134 460 | 3 076 818 |
2018-08-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 85 978 | −4,34 | 37,48 | −146 172 | 3 222 455 |
2018-07-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 700 | 89 878 | −1,86 | 37,53 | −63 801 | 3 373 121 |
2018-07-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 91 578 | −2,35 | 36,55 | −80 410 | 3 347 176 |
2018-07-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 93 778 | −0,11 | 39,45 | −3 945 | 3 699 542 |
2018-07-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 800 | 93 878 | −3,89 | 39,02 | −148 276 | 3 663 120 |
2018-07-11 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −6 100 | 97 678 | −5,88 | 40,54 | −247 294 | 3 959 866 |
2018-07-11 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −22 300 | 103 778 | −17,69 | 39,93 | −890 439 | 4 143 856 |
2018-07-11 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 141 | 126 078 | −1,67 | 40,63 | −86 989 | 5 122 549 |
2018-07-11 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −27 859 | 128 219 | −17,85 | 39,88 | −1 111 017 | 5 113 374 |
2018-06-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 156 078 | −0,32 | 39,40 | −19 700 | 6 149 473 |
2018-06-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 156 578 | −0,95 | 37,57 | −56 355 | 5 882 635 |
2018-06-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 700 | 158 078 | −1,06 | 40,79 | −69 343 | 6 448 002 |
2018-06-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 700 | 159 778 | −1,66 | 40,01 | −108 027 | 6 392 718 |
2018-06-06 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 000 | 162 478 | −0,61 | 48,59 | −48 590 | 7 894 806 |
2018-06-06 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 163 478 | −0,91 | 47,69 | −71 535 | 7 796 266 |
2018-06-06 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 900 | 164 978 | −1,14 | 46,53 | −88 407 | 7 676 426 |
2018-06-06 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 166 878 | −0,71 | 50,27 | −60 324 | 8 388 957 |
2018-06-06 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 200 | 168 078 | −1,87 | 49,51 | −158 432 | 8 321 542 |
2018-05-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 400 | 171 278 | −2,50 | 50,88 | −223 872 | 8 714 625 |
2018-05-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 175 678 | −0,51 | 53,64 | −48 276 | 9 423 368 |
2018-05-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 000 | 176 578 | −1,12 | 52,83 | −105 660 | 9 328 616 |
2018-05-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 178 578 | −0,83 | 51,67 | −77 505 | 9 227 125 |
2018-05-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 180 078 | −1,21 | 40,98 | −90 156 | 7 379 596 |
2018-05-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 182 278 | −1,19 | 40,08 | −88 176 | 7 305 702 |
2018-05-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 100 | 184 478 | −1,65 | 39,50 | −122 450 | 7 286 881 |
2018-05-10 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 187 578 | −0,69 | 38,35 | −49 855 | 7 193 616 |
2018-04-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 188 878 | −0,26 | 43,95 | −21 975 | 8 301 188 |
2018-04-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 900 | 189 378 | −2,02 | 42,63 | −166 257 | 8 073 184 |
2018-04-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 193 278 | −0,57 | 42,60 | −46 860 | 8 233 643 |
2018-04-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 300 | 194 378 | −1,67 | 41,99 | −138 567 | 8 161 932 |
2018-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 197 678 | −0,60 | 43,69 | −52 428 | 8 636 552 |
2018-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 200 | 198 878 | −1,58 | 42,63 | −136 416 | 8 478 169 |
2018-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 202 078 | −0,20 | 41,37 | −16 548 | 8 359 967 |
2018-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 000 | 202 478 | −1,94 | 40,77 | −163 080 | 8 255 028 |
2018-04-03 |
|
4/A | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 206 478 | −0,10 | 38,40 | −7 680 | 7 928 755 |
2018-03-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 206 478 | −0,10 | 38,40 | −7 680 | 7 928 755 |
2018-03-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 206 678 | −0,72 | 37,68 | −56 520 | 7 787 627 |
2018-03-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 700 | 208 178 | −1,28 | 36,63 | −98 901 | 7 625 560 |
2018-03-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 210 878 | −0,57 | 41,12 | −49 344 | 8 671 303 |
2018-03-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 200 | 212 078 | −1,49 | 39,72 | −127 104 | 8 423 738 |
2018-03-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 215 278 | −0,60 | 42,59 | −55 367 | 9 168 690 |
2018-03-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 100 | 216 578 | −1,41 | 41,75 | −129 425 | 9 042 132 |
2018-03-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 219 678 | −0,72 | 42,95 | −68 720 | 9 435 170 |
2018-03-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 800 | 221 278 | −1,25 | 41,87 | −117 236 | 9 264 910 |
2018-03-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 224 078 | −0,13 | 46,65 | −13 995 | 10 453 239 |
2018-03-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 224 378 | −0,31 | 46,17 | −32 319 | 10 359 532 |
2018-02-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 225 078 | −0,62 | 45,00 | −63 000 | 10 128 510 |
2018-02-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 226 478 | −0,70 | 44,03 | −70 448 | 9 971 826 |
2018-02-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 228 078 | −0,70 | 42,74 | −68 384 | 9 748 054 |
2018-02-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 911 | 229 678 | −1,25 | 44,55 | −129 685 | 10 232 155 |
2018-02-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 589 | 232 589 | −0,68 | 43,60 | −69 280 | 10 140 880 |
2018-02-22 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −8 700 | 234 178 | −3,58 | 45,28 | −393 936 | 10 603 580 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 242 878 | −0,12 | 48,43 | −14 529 | 11 762 582 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −5 100 | 243 178 | −2,05 | 47,91 | −244 341 | 11 650 658 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 248 278 | −0,64 | 46,55 | −74 480 | 11 557 341 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 000 | 249 878 | −1,19 | 45,44 | −136 320 | 11 354 456 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −3 938 | 0 | −100,00 | ||||
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 3 938 | 812 613 | 0,49 | ||||
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 252 878 | −0,12 | 48,25 | −14 475 | 12 201 364 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 767 | 253 178 | −1,85 | 47,56 | −226 719 | 12 041 146 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 433 | 257 945 | −0,93 | 46,71 | −113 645 | 12 048 611 |
2018-02-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 500 | 260 378 | −0,95 | 45,58 | −113 950 | 11 868 029 |
2018-02-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 100 | 262 878 | −1,17 | 49,25 | −152 675 | 12 946 742 |
2018-02-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −5 800 | 265 978 | −2,13 | 48,42 | −280 836 | 12 878 655 |
2018-02-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 000 | 271 778 | −0,37 | 46,94 | −46 940 | 12 757 259 |
2018-02-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 272 778 | −0,04 | 45,05 | −4 505 | 12 288 649 |
2018-02-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −10 000 | 272 878 | −3,54 | 45,10 | −451 000 | 12 306 798 |
2018-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 282 878 | −0,11 | 41,70 | −12 510 | 11 796 013 |
2018-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 283 178 | −0,14 | 40,79 | −16 316 | 11 550 831 |
2018-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 283 578 | −0,14 | 38,68 | −15 472 | 10 968 797 |
2018-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 283 978 | −0,39 | 37,43 | −41 173 | 10 629 297 |
2018-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 285 078 | −0,77 | 36,59 | −80 498 | 10 431 004 |
2018-02-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 400 | 287 278 | −1,51 | 37,15 | −163 460 | 10 672 378 |
2018-02-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 130 000 | 130 000 | |||||
2018-02-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
A - Award | 65 000 | 808 675 | 8,74 | ||||
2018-01-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 100 | 291 678 | −0,71 | 36,98 | −77 658 | 10 786 252 |
2018-01-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −6 100 | 293 778 | −2,03 | 36,54 | −222 894 | 10 734 648 |
2018-01-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 299 878 | −0,37 | 35,46 | −39 006 | 10 633 674 |
2018-01-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 300 978 | −0,07 | 34,68 | −6 936 | 10 437 917 |
2018-01-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −8 400 | 301 178 | −2,71 | 34,23 | −287 532 | 10 309 323 |
2018-01-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 309 578 | −0,45 | 33,22 | −46 508 | 10 284 181 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 310 978 | −0,70 | 34,99 | −76 978 | 10 881 120 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 100 | 313 178 | −1,29 | 34,40 | −141 040 | 10 773 323 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −8 100 | 317 278 | −2,49 | 33,20 | −268 920 | 10 533 630 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −8 516 | 325 378 | −2,55 | 36,15 | −307 853 | 11 762 415 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −15 084 | 333 894 | −4,32 | 35,45 | −534 728 | 11 836 542 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 348 978 | −0,14 | 34,05 | −17 025 | 11 882 701 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 000 | 349 478 | −0,57 | 34,04 | −68 080 | 11 896 231 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −6 500 | 351 478 | −1,82 | 33,08 | −215 020 | 11 626 892 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 000 | 357 978 | −0,28 | 32,17 | −32 170 | 11 516 152 |
2018-01-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 358 978 | −0,14 | 30,93 | −15 465 | 11 103 190 |
2018-01-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 359 478 | −0,17 | 30,38 | −18 228 | 10 920 942 |
2018-01-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 360 078 | −0,03 | 30,05 | −3 005 | 10 820 344 |
2018-01-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −17 500 | 360 178 | −4,63 | 22,01 | −385 175 | 7 927 518 |
2018-01-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 500 | 377 678 | −0,66 | 21,49 | −53 725 | 8 116 300 |
2018-01-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 100 | 380 178 | −1,07 | 20,38 | −83 558 | 7 748 028 |
2018-01-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 500 | 384 278 | −1,16 | 19,64 | −88 380 | 7 547 220 |
2018-01-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 700 | 388 778 | −0,69 | 20,28 | −54 756 | 7 884 418 |
2018-01-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 900 | 391 478 | −0,74 | 19,04 | −55 216 | 7 453 741 |
2018-01-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −14 400 | 394 378 | −3,52 | 18,24 | −262 656 | 7 193 455 |
2018-01-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 408 778 | −0,54 | 15,15 | −33 330 | 6 192 987 |
2017-12-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 410 978 | −0,53 | 14,73 | −32 406 | 6 053 706 |
2017-12-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 413 178 | −0,53 | 14,56 | −32 032 | 6 015 872 |
2017-12-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 415 378 | −0,53 | 14,40 | −31 680 | 5 981 443 |
2017-12-01 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 417 578 | −0,52 | 14,09 | −30 998 | 5 883 674 |
2017-11-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 908 | 3 938 | −60,00 | ||||
2017-11-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 908 | 743 675 | 0,80 | ||||
2017-11-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 419 778 | −0,52 | 13,41 | −29 502 | 5 629 223 |
2017-11-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 421 978 | −0,52 | 13,53 | −29 766 | 5 709 362 |
2017-10-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 424 178 | −0,52 | 13,60 | −29 920 | 5 768 821 |
2017-10-30 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 426 378 | −0,51 | 13,57 | −29 854 | 5 785 949 |
2017-10-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 428 578 | −0,51 | 14,78 | −32 516 | 6 334 383 |
2017-10-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 430 778 | −0,51 | 15,25 | −33 550 | 6 569 364 |
2017-09-21 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 432 978 | −0,51 | 15,56 | −34 232 | 6 737 138 |
2017-09-21 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 435 178 | −0,50 | 15,51 | −34 122 | 6 749 611 |
2017-09-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 437 378 | −0,50 | 14,98 | −32 956 | 6 551 922 |
2017-09-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 439 578 | −0,50 | 15,05 | −33 110 | 6 615 649 |
2017-08-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 441 778 | −0,50 | 13,51 | −29 722 | 5 968 421 |
2017-08-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 443 978 | −0,49 | 13,56 | −29 832 | 6 020 342 |
2017-08-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 908 | 9 846 | −37,50 | ||||
2017-08-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 908 | 737 767 | 0,81 | ||||
2017-08-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 446 178 | −0,49 | 14,58 | −32 076 | 6 505 275 |
2017-08-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 448 378 | −0,49 | 14,75 | −32 450 | 6 613 576 |
2017-07-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 450 578 | −0,04 | 16,79 | −3 358 | 7 565 205 |
2017-07-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 500 | 450 778 | −0,55 | 15,97 | −39 925 | 7 198 925 |
2017-07-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 453 278 | −0,07 | 17,32 | −5 196 | 7 850 775 |
2017-07-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 500 | 453 578 | −0,55 | 16,89 | −42 225 | 7 660 932 |
2017-05-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 450 | 456 078 | −0,75 | 13,26 | −45 747 | 6 047 594 |
2017-05-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 450 | 459 528 | −0,75 | 13,44 | −46 368 | 6 176 056 |
2017-05-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 462 978 | −0,52 | 14,94 | −35 856 | 6 916 891 |
2017-05-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 465 378 | −0,51 | 14,88 | −35 712 | 6 924 825 |
2017-05-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 908 | 15 754 | −27,27 | ||||
2017-05-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 908 | 731 859 | 0,81 | ||||
2017-04-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 467 778 | −0,76 | 17,78 | −64 008 | 8 317 093 |
2017-04-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 471 378 | −0,32 | 17,70 | −26 550 | 8 343 391 |
2017-04-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 100 | 472 878 | −0,44 | 17,07 | −35 847 | 8 072 027 |
2017-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 200 | 474 978 | −0,88 | 16,99 | −71 358 | 8 069 876 |
2017-04-12 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 000 | 479 178 | −0,62 | 17,08 | −51 240 | 8 184 360 |
2017-03-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −418 | 482 178 | −0,09 | 19,86 | −8 301 | 9 576 055 |
2017-03-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 182 | 482 596 | −0,66 | 18,99 | −60 426 | 9 164 498 |
2017-03-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −12 400 | 485 778 | −2,49 | 20,34 | −252 216 | 9 880 725 |
2017-03-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −17 600 | 498 178 | −3,41 | 20,01 | −352 176 | 9 968 542 |
2017-03-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 515 778 | −0,46 | 18,50 | −44 400 | 9 541 893 |
2017-03-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −10 800 | 518 178 | −2,04 | 18,54 | −200 232 | 9 607 020 |
2017-02-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 348 978 | −0,68 | 15,57 | −37 368 | 5 433 587 |
2017-02-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 907 | 21 662 | −21,43 | ||||
2017-02-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 351 378 | −0,68 | 15,54 | −37 296 | 5 460 414 |
2017-02-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 907 | 725 951 | 0,82 | ||||
2017-02-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
A - Award | 165 000 | 720 044 | 29,73 | ||||
2017-02-06 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 353 778 | −0,67 | 13,87 | −33 288 | 4 906 901 |
2017-02-06 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 356 178 | −0,67 | 13,45 | −32 280 | 4 790 594 |
2017-01-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 358 578 | −0,66 | 14,47 | −34 728 | 5 188 624 |
2017-01-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 360 978 | −0,99 | 14,08 | −50 688 | 5 082 570 |
2017-01-09 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −6 000 | 364 578 | −1,62 | 17,10 | −102 600 | 6 234 284 |
2017-01-09 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 370 578 | −0,64 | 16,36 | −39 264 | 6 062 656 |
2016-12-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 372 978 | −0,64 | 15,25 | −36 600 | 5 687 914 |
2016-12-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 375 378 | −0,03 | 15,82 | −1 582 | 5 938 480 |
2016-12-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 300 | 375 478 | −0,61 | 15,17 | −34 891 | 5 696 001 |
2016-12-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 377 778 | −0,94 | 17,30 | −62 280 | 6 535 559 |
2016-12-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 381 378 | −0,94 | 18,55 | −66 780 | 7 074 562 |
2016-11-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 384 978 | −0,28 | 19,22 | −21 142 | 7 399 277 |
2016-11-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 500 | 386 078 | −0,64 | 18,40 | −46 000 | 7 103 835 |
2016-11-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −8 400 | 388 578 | −2,12 | 18,21 | −152 964 | 7 076 005 |
2016-11-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 908 | 27 569 | −17,65 | ||||
2016-11-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 908 | 555 044 | 1,08 | ||||
2016-10-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 396 978 | −0,60 | 13,70 | −32 880 | 5 438 599 |
2016-10-28 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 399 378 | −0,60 | 13,91 | −33 384 | 5 555 348 |
2016-10-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 401 778 | −0,59 | 16,01 | −38 424 | 6 432 466 |
2016-10-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 404 178 | −0,59 | 15,91 | −38 184 | 6 430 472 |
2016-09-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 406 578 | −0,07 | 21,82 | −6 546 | 8 871 532 |
2016-09-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 500 | 406 878 | −1,09 | 21,40 | −96 300 | 8 707 189 |
2016-09-29 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −7 200 | 411 378 | −1,72 | 20,50 | −147 600 | 8 433 249 |
2016-09-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
A - Award | 320 000 | 549 136 | 139,66 | ||||
2016-09-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 418 578 | −0,85 | 19,32 | −69 552 | 8 086 927 |
2016-09-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 422 178 | −0,85 | 19,39 | −69 804 | 8 186 031 |
2016-08-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 425 778 | −1,11 | 22,08 | −105 984 | 9 401 178 |
2016-08-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 430 578 | −1,10 | 22,58 | −108 384 | 9 722 451 |
2016-08-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 908 | 33 477 | −15,00 | ||||
2016-08-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 908 | 229 136 | 2,65 | ||||
2016-08-17 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
G - Gift | −330 957 | 0 | −100,00 | ||||
2016-07-21 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 315 511 | −1,50 | 22,22 | −106 656 | 7 010 654 |
2016-07-21 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 320 311 | −1,48 | 21,99 | −105 552 | 7 043 639 |
2016-07-11 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 325 111 | −1,45 | 22,96 | −110 208 | 7 464 549 |
2016-07-11 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 329 911 | −1,43 | 22,80 | −109 440 | 7 521 971 |
2016-06-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 334 711 | −1,41 | 21,32 | −102 336 | 7 136 039 |
2016-06-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 339 511 | −1,39 | 21,19 | −101 712 | 7 194 238 |
2016-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −4 800 | 344 311 | −1,37 | 20,79 | −99 792 | 7 158 226 |
2016-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 349 111 | −0,34 | 20,90 | −25 080 | 7 296 420 |
2016-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −6 000 | 350 311 | −1,68 | 20,25 | −121 500 | 7 093 798 |
2016-05-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 356 311 | −1,00 | 17,35 | −62 460 | 6 181 996 |
2016-05-27 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 359 911 | −0,99 | 18,03 | −64 908 | 6 489 195 |
2016-05-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 907 | 39 385 | −13,04 | ||||
2016-05-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 907 | 223 228 | 2,72 | ||||
2016-04-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 363 511 | −0,03 | 20,15 | −2 015 | 7 324 747 |
2016-04-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 363 611 | −0,33 | 20,12 | −24 144 | 7 315 853 |
2016-04-13 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 364 811 | −0,33 | 20,20 | −24 240 | 7 369 182 |
2016-04-13 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −12 010 | 366 011 | −3,18 | 20,42 | −245 244 | 7 473 945 |
2016-04-04 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −890 | 378 021 | −0,23 | 20,04 | −17 836 | 7 575 541 |
2016-04-04 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 378 911 | −0,08 | 20,01 | −6 003 | 7 582 009 |
2016-02-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 908 | 45 292 | −11,54 | ||||
2016-02-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 908 | 217 321 | 2,79 | ||||
2016-02-11 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
A - Award | 163 973 | 211 413 | 345,64 | ||||
2016-01-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 379 211 | −0,32 | 20,07 | −24 084 | 7 610 765 |
2016-01-15 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 380 411 | −0,31 | 20,32 | −24 384 | 7 729 952 |
2016-01-04 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −800 | 381 611 | −0,21 | 27,17 | −21 736 | 10 368 371 |
2016-01-04 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 382 411 | −0,10 | 26,00 | −10 400 | 9 942 686 |
2016-01-04 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 382 811 | −0,31 | 25,21 | −30 252 | 9 650 665 |
2015-12-21 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 220 000 | 220 000 | |||||
2015-12-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 384 011 | −0,05 | 22,21 | −4 442 | 8 528 884 |
2015-12-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 384 211 | −0,18 | 21,55 | −15 085 | 8 279 747 |
2015-12-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 384 911 | −0,08 | 20,69 | −6 207 | 7 963 809 |
2015-12-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 385 211 | −0,03 | 25,84 | −2 584 | 9 953 852 |
2015-12-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 385 311 | −0,10 | 24,93 | −9 972 | 9 605 803 |
2015-12-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 385 711 | −0,08 | 23,34 | −7 002 | 9 002 495 |
2015-12-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 386 011 | −0,10 | 21,54 | −8 616 | 8 314 677 |
2015-12-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 386 411 | −0,31 | 37,93 | −45 516 | 14 656 569 |
2015-12-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −800 | 387 611 | −0,21 | 36,99 | −29 592 | 14 337 731 |
2015-12-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 388 411 | −0,15 | 38,54 | −23 124 | 14 969 360 |
2015-12-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 389 011 | −0,18 | 37,43 | −26 201 | 14 560 682 |
2015-12-07 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 389 711 | −0,18 | 36,21 | −25 347 | 14 111 435 |
2015-11-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 390 411 | −0,05 | 36,71 | −7 342 | 14 331 988 |
2015-11-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 390 611 | −0,23 | 35,80 | −32 220 | 13 983 874 |
2015-11-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 391 511 | −0,23 | 34,81 | −31 329 | 13 628 498 |
2015-11-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 800 | 392 411 | −0,71 | 34,74 | −97 272 | 13 632 358 |
2015-11-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 908 | 51 200 | −10,35 | ||||
2015-11-18 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 908 | 47 440 | 14,23 | ||||
2015-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 395 211 | −0,05 | 25,36 | −5 072 | 10 022 551 |
2015-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 000 | 395 411 | −0,25 | 24,36 | −24 360 | 9 632 212 |
2015-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 396 411 | −0,15 | 28,11 | −16 866 | 11 143 113 |
2015-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 397 011 | −0,08 | 27,67 | −8 301 | 10 985 294 |
2015-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 397 311 | −0,28 | 25,57 | −28 127 | 10 159 242 |
2015-10-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 398 411 | −0,05 | 36,00 | −7 200 | 14 342 796 |
2015-10-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 398 611 | −0,28 | 35,26 | −38 786 | 14 055 024 |
2015-10-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 399 711 | −0,17 | 33,71 | −23 597 | 13 474 258 |
2015-10-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 400 411 | −0,12 | 32,49 | −16 245 | 13 009 353 |
2015-10-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −800 | 400 911 | −0,20 | 31,64 | −25 312 | 12 684 824 |
2015-10-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 401 711 | −0,17 | 30,28 | −21 196 | 12 163 809 |
2015-09-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 402 411 | −0,37 | 43,06 | −64 590 | 17 327 818 |
2015-09-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 403 911 | −0,27 | 42,17 | −46 387 | 17 032 927 |
2015-09-25 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 600 | 405 011 | −0,64 | 43,29 | −112 554 | 17 532 926 |
2015-09-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 407 611 | −0,02 | 47,74 | −4 774 | 19 459 349 |
2015-09-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 700 | 407 711 | −0,42 | 46,83 | −79 611 | 19 093 106 |
2015-09-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −800 | 409 411 | −0,20 | 45,42 | −36 336 | 18 595 448 |
2015-09-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 410 211 | −0,10 | 46,73 | −18 692 | 19 169 160 |
2015-09-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 800 | 410 611 | −0,44 | 45,98 | −82 764 | 18 879 894 |
2015-09-14 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 412 411 | −0,10 | 44,67 | −17 868 | 18 422 399 |
2015-08-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 374 982 | −0,29 | 40,07 | −44 077 | 15 025 529 |
2015-08-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 376 082 | −0,40 | 39,20 | −58 800 | 14 742 414 |
2015-08-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 377 582 | −0,16 | 40,44 | −24 264 | 15 269 416 |
2015-08-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 378 182 | −0,13 | 39,44 | −19 720 | 14 915 498 |
2015-08-31 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 378 682 | −0,39 | 38,15 | −57 225 | 14 446 718 |
2015-08-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −5 907 | 57 108 | −9,37 | ||||
2015-08-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 5 907 | 41 532 | 16,58 | ||||
2015-08-03 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 380 182 | −0,16 | 57,45 | −34 470 | 21 841 456 |
2015-08-03 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 380 782 | −0,29 | 56,25 | −61 875 | 21 418 988 |
2015-08-03 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 381 882 | −0,24 | 55,41 | −49 869 | 21 160 082 |
2015-08-03 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 382 782 | −0,05 | 57,13 | −11 426 | 21 868 336 |
2015-08-03 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 382 982 | −0,62 | 56,05 | −134 520 | 21 466 141 |
2015-07-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −800 | 385 382 | −0,21 | 60,71 | −48 568 | 23 396 541 |
2015-07-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 800 | 386 182 | −0,46 | 59,90 | −107 820 | 23 132 302 |
2015-07-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 387 982 | −0,05 | 62,90 | −12 580 | 24 404 068 |
2015-07-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −690 | 388 182 | −0,18 | 61,70 | −42 573 | 23 950 829 |
2015-07-20 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 710 | 388 872 | −0,44 | 60,90 | −104 139 | 23 682 305 |
2015-07-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 390 582 | −0,03 | 50,65 | −5 065 | 19 782 978 |
2015-07-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 390 682 | −0,23 | 49,86 | −44 874 | 19 479 405 |
2015-07-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 391 582 | −0,18 | 48,40 | −33 880 | 18 952 569 |
2015-07-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 392 282 | −0,23 | 45,25 | −40 725 | 17 750 760 |
2015-07-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 393 182 | −0,13 | 53,61 | −26 805 | 21 078 487 |
2015-07-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 700 | 393 682 | −0,43 | 53,03 | −90 151 | 20 876 956 |
2015-07-02 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 395 382 | −0,10 | 51,65 | −20 660 | 20 421 480 |
2015-06-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 395 782 | −0,08 | 57,15 | −17 145 | 22 618 941 |
2015-06-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 396 082 | −0,18 | 55,77 | −39 039 | 22 089 493 |
2015-06-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 396 782 | −0,23 | 53,83 | −48 447 | 21 358 775 |
2015-06-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 397 682 | −0,18 | 52,62 | −36 834 | 20 926 027 |
2015-06-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 398 382 | −0,15 | 55,60 | −33 360 | 22 150 039 |
2015-06-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 000 | 398 982 | −0,50 | 54,86 | −109 720 | 21 888 153 |
2015-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 400 982 | −0,02 | 45,25 | −4 525 | 18 144 436 |
2015-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 401 082 | −0,22 | 44,64 | −40 176 | 17 904 300 |
2015-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 401 982 | −0,40 | 43,74 | −69 984 | 17 582 693 |
2015-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 403 582 | −0,12 | 43,15 | −21 575 | 17 414 563 |
2015-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 500 | 404 082 | −0,37 | 42,76 | −64 140 | 17 278 546 |
2015-06-08 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 800 | 405 582 | −0,44 | 41,22 | −74 196 | 16 718 090 |
2015-05-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 407 382 | −0,15 | 38,16 | −22 896 | 15 545 697 |
2015-05-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 407 982 | −0,34 | 37,40 | −52 360 | 15 258 527 |
2015-05-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 409 382 | −0,15 | 38,47 | −23 082 | 15 748 926 |
2015-05-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 409 982 | −0,34 | 37,06 | −51 884 | 15 193 933 |
2015-05-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
G - Gift | 19 082 | 411 382 | 4,86 | ||||
2015-05-26 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
G - Gift | −19 082 | 35 625 | −34,88 | ||||
2015-05-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Units |
M - Exercise | −31 508 | 63 015 | −33,33 | ||||
2015-05-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
F - Taxes | −14 801 | 54 707 | −21,29 | 37,30 | −552 077 | 2 040 571 | |
2015-05-19 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
M - Exercise | 31 508 | 69 508 | 82,92 | ||||
2015-04-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 600 | 392 300 | −0,66 | 62,70 | −163 020 | 24 597 210 |
2015-04-24 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
S - Sale | X | −2 600 | 394 900 | −0,65 | 60,01 | −156 026 | 23 697 949 |
2015-01-21 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 126 667 | 126 667 | |||||
2015-01-21 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
A - Award | 38 000 | 38 000 | |||||
2014-10-23 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Restricted Stock Unit |
A - Award | 94 523 | 94 523 | |||||
2014-10-16 |
|
4 | ATRA |
Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | 155 000 | 155 000 | |||||
2014-10-15 | 3 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
2 132 306 | ||||||||
2014-10-15 | 3 | ATRA |
Atara Biotherapeutics, Inc.
Common Stock |
2 132 306 |